Skip to content

Clinical trials

Phase 3 Muscular Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Diseases Phase: Phase 3 Country / region: United Kingdom Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20171
20212
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Active, not recruiting2
Completed2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
PTC Therapeutics2
Avidity Biosciences, Inc.1
Calcilytix Therapeutics, Inc., a BridgeBio company1
Kyntra Bio1
Stealth BioTherapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Diseases8
Musculoskeletal Diseases5
Genetic Diseases, Inborn4
Muscular Disorders, Atrophic4
Muscular Dystrophies4
Muscular Dystrophy, Duchenne4
Nervous System Diseases4
Neuromuscular Diseases4
Genetic Diseases, X-Linked3
Bulbo-Spinal Atrophy, X-Linked2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.